1. Home
  2. PGEN vs PMO Comparison

PGEN vs PMO Comparison

Compare PGEN & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • PMO
  • Stock Information
  • Founded
  • PGEN 1998
  • PMO 1993
  • Country
  • PGEN United States
  • PMO United States
  • Employees
  • PGEN N/A
  • PMO N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • PMO Finance Companies
  • Sector
  • PGEN Health Care
  • PMO Finance
  • Exchange
  • PGEN Nasdaq
  • PMO Nasdaq
  • Market Cap
  • PGEN 344.0M
  • PMO 287.4M
  • IPO Year
  • PGEN N/A
  • PMO N/A
  • Fundamental
  • Price
  • PGEN $1.53
  • PMO $9.64
  • Analyst Decision
  • PGEN Strong Buy
  • PMO
  • Analyst Count
  • PGEN 4
  • PMO 0
  • Target Price
  • PGEN $7.33
  • PMO N/A
  • AVG Volume (30 Days)
  • PGEN 1.4M
  • PMO 99.0K
  • Earning Date
  • PGEN 05-13-2025
  • PMO 01-01-0001
  • Dividend Yield
  • PGEN N/A
  • PMO 4.10%
  • EPS Growth
  • PGEN N/A
  • PMO N/A
  • EPS
  • PGEN N/A
  • PMO 0.42
  • Revenue
  • PGEN $3,925,000.00
  • PMO N/A
  • Revenue This Year
  • PGEN $189.12
  • PMO N/A
  • Revenue Next Year
  • PGEN $1,093.07
  • PMO N/A
  • P/E Ratio
  • PGEN N/A
  • PMO $24.38
  • Revenue Growth
  • PGEN N/A
  • PMO N/A
  • 52 Week Low
  • PGEN $0.65
  • PMO $8.57
  • 52 Week High
  • PGEN $2.17
  • PMO $10.68
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 52.21
  • PMO 35.73
  • Support Level
  • PGEN $1.33
  • PMO $9.56
  • Resistance Level
  • PGEN $1.49
  • PMO $9.77
  • Average True Range (ATR)
  • PGEN 0.14
  • PMO 0.21
  • MACD
  • PGEN 0.02
  • PMO -0.00
  • Stochastic Oscillator
  • PGEN 95.45
  • PMO 30.73

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About PMO Putnam Municipal Opportunities Trust

Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, tax bonds, local debt, state debt, and education.

Share on Social Networks: